tiprankstipranks
Trending News
More News >
Allergy Therapeutics PLC (GB:AGY)
LSE:AGY
UK Market

Allergy Therapeutics (AGY) Income Statement

Compare
17 Followers

Allergy Therapeutics Income Statement

Last quarter (Q4 2025), Allergy Therapeutics's total revenue was £21.01M, an increase of 6.75% from the same quarter last year. In Q4, Allergy Therapeutics's net income was £-29.05M. See Allergy Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 55.04M£ 55.20M£ 59.59M£ 72.77M£ 84.33M
Gross Profit
£ 25.13M£ 29.74M£ 32.69M£ 48.95M£ 61.80M
Operating Expenses
£ 54.63M£ 64.99M£ 72.90M£ 61.95M£ 59.16M
Depreciation and Amortization
£ 4.17M£ 4.32M£ 4.22M£ 4.17M£ 4.13M
EBITDA
£ -29.43M£ -30.74M£ -36.24M£ -8.69M£ 7.61M
Operating Income
£ -29.50M£ -35.26M£ -34.85M£ -13.00M£ 4.03M
Other Income/Expenses
£ -10.94M£ -3.91M£ -7.77M£ -396.00K£ -374.00K
Pretax Income
£ -40.44M£ -39.17M£ -42.62M£ -13.40M£ 3.66M
Net Income
£ -40.13M£ -40.22M£ -43.07M£ -13.78M£ 2.89M
Per Share Metrics
Basic EPS
£ -0.01£ -0.01£ -0.06£ -0.02£ 0.00
Diluted EPS
£ -0.01£ -0.01£ -0.06£ -0.02£ 0.00
Weighted Average Shares Outstanding
4.77B 3.74B 669.84M 643.02M 671.32M
Weighted Average Shares Outstanding (Diluted)
4.77B 3.74B 670.36M 642.99M 676.66M
Currency in GBP

Allergy Therapeutics Earnings and Revenue History